These results collectively indicate that GATA6 influences the metabolic phenotype of lung cancer cells by modulating the expression of glucose-related metabolic proteins, ultimately resulting in the inhibition of lung cancer cell proliferation and metastasis. This evidence concerns the gene GATA6 and lung carcinoma.